Literature DB >> 25370869

Molecular spectrum of α-globin gene defects in the Omani population.

Suha M Hassan1, Cornelis L Harteveld, Egbert Bakker, Piero C Giordano.   

Abstract

We describe the molecular characterization of α-globin gene defects in a cohort of 634 Omani patients. A total of 21 different α gene mutations were found in 484 subjects. Overall, we identified three different large deletions, three small deletions, 11 point mutations [two on the α2 polyadenylation signal (polyA) (HBA2: c.*94A>G), and nine α chain variants], three ααα(anti 3.7) triplication, a 21 nucleotide (nt) duplication on the α1 gene and two novel (presumed) polymorphisms on the α 3.7 kb hybrid gene, namely -5 (C>T) and +46 (C>A). Of these defects, 15 have not been previously reported in the Omani population. This large heterogeneity of α-thalassemia (α-thal) observed in the Omani population could be expected in neighboring Arab countries. The high frequency of α-thal, solely or in association with β-globin gene defects, emphasize the necessity of adding α-thal testing to pre marital programs for accurate genetic counseling.

Entities:  

Keywords:  Oman; α gene mutation spectrum; α variant; α-thalassemia (α-thal)

Mesh:

Substances:

Year:  2014        PMID: 25370869     DOI: 10.3109/03630269.2014.976414

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  2 in total

1.  Alpha-globin gene triplication and its effect in beta-thalassemia carrier, sickle cell trait, and healthy individual.

Authors:  Mohammad Hamid; Bijan Keikhaei; Hamid Galehdari; Alihossein Saberi; Alireza Sedaghat; Gholamreza Shariati; Marziye Mohammadi-Anaei
Journal:  EJHaem       Date:  2021-07-19

2.  Comprehensive haematological indices reference intervals for a healthy Omani population: First comprehensive study in Gulf Cooperation Council (GCC) and Middle Eastern countries based on age, gender and ABO blood group comparison.

Authors:  Adhra Al-Mawali; Avinash Daniel Pinto; Raiya Al-Busaidi; Rabab H Al-Lawati; Magdi Morsi
Journal:  PLoS One       Date:  2018-04-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.